Zoledronic acid reverses cisplatin resistance in nasopharyngeal carcinoma cells by activating the mitochondrial apoptotic pathway.

You, Yanjie; Li, Haijun; Chen, Jiongyu; Qin, Xin; Ran, Yonggang

You, Yanjie; Li, Haijun; Chen, Jiongyu; Qin, Xin; Ran, Yonggang.

Afiliación

You Y; Pathological Examination and Research Center, Luohe Medical College, Luohe, Henan 462002, P.R. China.
Li H; Department of Radiation Oncology, The Second People's Hospital of Neijiang, Neijiang, Sichuan 641000, P.R. China.
Chen J; Department of Laboratory, Cancer Hospital of Shantou University, Shantou, Guangdong 515041, P.R. China.
Qin X; Medical College, Hubei University of Arts and Science, Xiangyang, Hubei 441053, P.R. China.
Ran Y; Department of Teaching and Training, Bethune Military Medical NCO Academy of PLA, Shijiazhuang, Hebei 050081, P.R. China.

Oncol Lett ; 13(3): 1840-1846, 2017 Mar.

Article en En | MEDLINE | ID: mdl-28454332

Palabras clave

chemotherapy; cisplatin; drug resistance; nasopharyngeal carcinoma; zoledronic acid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google